Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review
-
- Anand Maurya
- 1 Faculty of Ayurveda, Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
-
- Anurag Kumar Singh
- 2 Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
-
- Gaurav Mishra
- 1 Faculty of Ayurveda, Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
-
- Komal Kumari
- 3 Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Ajmer, India
-
- Arati Rai
- 4 Department of Pharmacy, Hygia Institute of Pharmaceutical Education and Research, Lucknow, India
-
- Bhupesh Sharma
- 5 Amity Institute of Pharmacy, Amity University, Noida, India
-
- Giriraj T. Kulkarni
- 5 Amity Institute of Pharmacy, Amity University, Noida, India
-
- Rajendra Awasthi
- 5 Amity Institute of Pharmacy, Amity University, Noida, India
抄録
<jats:p>Since the development of first lipid-based nanocarrier system, about 15% of the present pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is an advanced area to meliorate the delivery of compounds for improved medical diagnosis and curing disease. Nanomedicines are gaining significant interest due to the ultra small size and large surface area to mass ratio. In this review, we discuss the potential of nanotechnology in delivering of active moieties for the disease therapy including their toxicity evidences. This communication will help the formulation scientists in understanding and exploring the new aspects of nanotechnology in the field of nanomedicine.</jats:p>
収録刊行物
-
- Interventional Medicine and Applied Science
-
Interventional Medicine and Applied Science 11 (1), 38-54, 2019-03
Akademiai Kiado Zrt.